News Website

FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer - Pharmaceutical Executive

FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer Pharmaceutical Executive

Published: June 17, 2024, 7 a.m.

Read Full Article

Molecular Imaging in Gynecology: Beyond Cancer - Journal of Nuclear Medicine

Molecular Imaging in Gynecology: Beyond Cancer Journal of Nuclear Medicine

Published: June 13, 2024, 7 a.m.

Read Full Article

Adding Immunotherapy to Chemotherapy for Endometrial Cancer - Cleveland Clinic

Adding Immunotherapy to Chemotherapy for Endometrial Cancer Cleveland Clinic

Published: June 13, 2024, 7 a.m.

Read Full Article

Abemaciclib Plus Fulvestrant Demonstrates Activity in Advanced Endometrial Cancer - Cancer Therapy Advisor

Abemaciclib Plus Fulvestrant Demonstrates Activity in Advanced Endometrial Cancer Cancer Therapy Advisor

Published: June 11, 2024, 7 a.m.

Read Full Article

Weight Loss Drugs, Like Mounjaro, Taken By RHONJ Alum, May Reduce Endometrial Cancer Risk - SurvivorNet

Weight Loss Drugs, Like Mounjaro, Taken By RHONJ Alum, May Reduce Endometrial Cancer Risk SurvivorNet

Published: June 11, 2024, 7 a.m.

Read Full Article

Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets - The ASCO Post

Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets The ASCO Post

Published: June 10, 2024, 7 a.m.

Read Full Article

Endometriosis increases risks for ovarian, endometrial cancers - Healio

Endometriosis increases risks for ovarian, endometrial cancers Healio

Published: June 7, 2024, 7 a.m.

Read Full Article

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone Medpage Today

Published: June 5, 2024, 7 a.m.

Read Full Article

Leading Cancer Researchers from NYU Langone’s Perlmutter Cancer Center Present Latest Clinical Findings & Research at ASCO 2024 Annual Conference - NYU Langone Health

Leading Cancer Researchers from NYU Langone’s Perlmutter Cancer Center Present Latest Clinical Findings & Research at ASCO 2024 Annual Conference NYU Langone Health

Published: June 3, 2024, 7 a.m.

Read Full Article

Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis - Frontiers

Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis Frontiers

Published: June 2, 2024, 7 a.m.

Read Full Article

Latest Articles

FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer - Pharmaceutical Executive

Molecular Imaging in Gynecology: Beyond Cancer - Journal of Nuclear Medicine

Adding Immunotherapy to Chemotherapy for Endometrial Cancer - Cleveland Clinic

Abemaciclib Plus Fulvestrant Demonstrates Activity in Advanced Endometrial Cancer - Cancer Therapy Advisor

Weight Loss Drugs, Like Mounjaro, Taken By RHONJ Alum, May Reduce Endometrial Cancer Risk - SurvivorNet

Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets - The ASCO Post

Endometriosis increases risks for ovarian, endometrial cancers - Healio

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today

Leading Cancer Researchers from NYU Langone’s Perlmutter Cancer Center Present Latest Clinical Findings & Research at ASCO 2024 Annual Conference - NYU Langone Health

Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis - Frontiers

Subscribe to Our Newsletter